Could early heart pump support save more lives in severe shock?

NCT ID NCT07027202

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding a balloon pump early to reduce pressure on the heart improves survival and recovery in 298 adults on ECMO for severe cardiogenic shock. Participants are randomly assigned to early preventive unloading or standard care with rescue unloading only if needed. The goal is to see if early intervention reduces deaths, complications, and time on life support.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOGENIC SHOCK ACUTE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • APHP - hôpital Pitié-Salpêtrière

    RECRUITING

    Paris, 75013, France

  • APHP - hôpital Pitié-Salpêtrière

    NOT_YET_RECRUITING

    Paris, 75013, France

  • APHP - hôpital Pitié-Salpêtrière

    NOT_YET_RECRUITING

    Paris, 75013, France

  • CHRU Nancy - hôpitaux de brabois

    NOT_YET_RECRUITING

    Vandœuvre-lès-Nancy, 54500, France

  • CHU Clermont-Ferrand - Site Gabriel Montpied

    NOT_YET_RECRUITING

    Clermont-Ferrand, 63000, France

  • Henri Mondor

    NOT_YET_RECRUITING

    Créteil, 94000, France

  • Hôpital Cardiologique

    NOT_YET_RECRUITING

    Lille, 59000, France

  • Hôpital Européen Georges Pompidou

    NOT_YET_RECRUITING

    Paris, 75015, France

  • Hôpital Rangueil

    NOT_YET_RECRUITING

    Toulouse, 31059, France

  • Hôpital du Pontchaillou

    NOT_YET_RECRUITING

    Rennes, 35033, France

  • Nouvel Hôpital Civil

    NOT_YET_RECRUITING

    Strasbourg, 67000, France

  • Nouvel hôpital civil

    NOT_YET_RECRUITING

    Strasbourg, 67000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.